$Arcturus Therapeutics (ARCT.US)$ September 7: Replicate Bio...
$Arcturus Therapeutics(ARCT.US$ September 7: Replicate Bioscience raises $40 million to develop next-generation MRNA therapies
1. Replicate Bioscience is a biomedical company that designs unique self-replicating RNA(srRNA) in synthetic biology to develop next-generation mRNA therapies.
2. Replicate core technology self-amplifying RNA (saRNA) allows you to amplify more RNA in the body than the first generation oF mRNA vaccines. Because of the time end in the body, it requires multiple and massive doses and increases the toxic side effects. The technical goal is to address these deficiencies.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment